✦ LIBER ✦

Clinical Value of Measuring Trough Levels and Human Anti-Chimeric Antibodies in Patients With Inflammatory Bowel Disease Who Lost Response to Infliximab Therapy

✍ Scribed by Pariente, Benjamin ;Pineton de Chambrun, Guillaume ;Desroches, Marine ;De Cassan, Chiara ;Gornet, Jean-Marc ;Desreumaux, Pierre ;Krzysiek, Roman ;Emilie, Dominique ;Colombel, Jean-Frederic ;Allez, Matthieu

Book ID: 122168484
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 101 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)61111-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

962 Clinical Utility of Measuring Inflix

962 Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Levels in Patients with Inflammatory Bowel Disease

✍ Waqqas Afif; Edward V. Loftus; William A. Faubion; Karen A. Hanson; William J. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Trough levels and antibodies to inflixim

Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

✍ Benjamin Pariente; Guillaume Pineton de Chambrun; Roman Krzysiek; Marine Desroch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBO

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN THE EVALUATION OF LOSS OF RESPONSE AND INFUSION REACTIONS TO INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE

✍ Marzo, M.; Armuzzi, A.; Felice, C.; Pugliese, D.; Andrisani, G.; Tolusso, B.; Gr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Addition of an Immunomodulator to Inflix

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

✍ Ben–Horin, Shomron; Waterman, Matti; Kopylov, Uri; Yavzori, Miri; Picard, Orit; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 439 KB

P544 Does measuring IFX and human anti-c

P544 Does measuring IFX and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease impact clinical management? A Canadian experience

✍ Chauhan, U.; Dutta, U.; Armstrong, D.; Marshall, J.; Tse, F.; Greenwald, E.; Xen 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Impact of Antibodies to Infliximab on Cl

Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis

✍ Nanda, Kavinderjit S; Cheifetz, Adam S; Moss, Alan C 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB